Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

ABSTRACT: We analyzed using quantitative real-time PCR (qRT-PCR), gene expression of 65 potential leukemia associated antigens in de-identified, clinically annotated samples from ficoll purified peripheral blood samples from 30 newly diagnosed untreated AML patients collected under IRB-approved protocols from three NCCN cancer centers.

ORGANISM(S): Homo sapiens

PROVIDER: GSE52756 | GEO | 2016/11/24

SECONDARY ACCESSION(S): PRJNA229971

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

Project description:We analyzed using quantitative real-time PCR (qRT-PCR), gene expression of 65 potential leukemia associated antigens in de-identified, clinically annotated samples from ficoll purified peripheral blood samples from 22 newly diagnosed untreated AML patients collected under IRB-approved protocols from three NCCN cancer centers.

2017-01-21 | GSE53948 | GEO

Expression of putative leukemia-associated antigens in healthy human tissues

Project description:We analyzed using quantitative real-time PCR (qRT-PCR), gene expression of 65 potential leukemia associated antigens in 12 healthy human tissue types

2017-01-21 | GSE54361 | GEO

Impaired B-lymphocyte immunity in acute myeloid leukemia patients after chemotherapy

Project description:We analyzed via microarray gene expression profiles in de-identified, clinically annotated samples from Ficoll-purified peripheral blood samples from 10 acute myeloid leukemia (AML) patients in remission and 10 healthy donors collected under IRB-approved protocols.

2017-08-11 | GSE97485 | GEO

Phosphoproteomics of primary human FLT3-ITD+ AML cells treated with gilteritinib

Project description:Primary human AML cells (newly diagnosed, prior to treatment initation) were obtained from donor after consent and AML blasts were isolated by standard Ficoll centrifugation. AML blasts were treated with FLT3 inhibitor gilteritinib (or DMSO vehicle control) at 10 nM concentration for 6 h, followed by harvest for LC/MS.

2022-08-25 | PXD034080 | Pride

Translatome proteomics of primary human FLT3-ITD+ AML cells treated with FLT3 inhibitors quizartinib, crenolanib, gilteritinib

Project description:Primary human AML cells (newly diagnosed, prior to treatment initation) was obtained from donor after consent and AML blasts were isolated by standard Ficoll centrifugation. Cells were treated ex vivo with DMSO vehicle control or 10 nM FLT3 inhibitors quizartinib, crenolanib, gilteritinib for 6 hours in SILAC medium and processed for LC/MS.

2022-08-25 | PXD034081 | Pride

PBMCs from patients with Sjögren's syndrome and healthy controls

Project description:Sjögren's syndrome is an autoimmune disease manifesting primarily as dryness of eyes and mouth. In this study, we compared gene expression in PBMCs between age- and gender-matched patients with Sjögren's syndrome (diagnosed by ACR criteria) and healthy controls. Cells were collected in heparinized tubes and PBMCs were prepared using Ficoll.

2013-09-05 | GSE48378 | GEO

Systematic Bias Introduced by Ficoll-Based Isolation in AML Sample Composition and Downstream Analyses

Project description:Acute myeloid leukemia (AML) is a heterogeneous malignancy whose characterization relies on immunophenotyping and molecular profiling. While red blood cell lysis is the recommended method for leukocyte isolation in clinical diagnostics, Ficoll-based density gradient centrifugation remains widely used in research and biobanking. Here, we systematically compare these two isolation approaches using paired primary AML samples. We show that Ficoll processing consistently enriches lymphocytes and AML blasts while depleting granulocytes. The increased T-cell content introduced by Ficoll impaired AML engraftment in immunodeficient NSG mice, as residual T cells in the graft triggered graft-versus-host disease, precluding reliable evaluation of leukemia-initiating activity. Although Ficoll had minimal impact on ex-vivo AML blast expansion or chemotherapy response, RNA sequencing identified 1,136 differentially expressed genes between isolation methods, with Ficoll samples exhibiting enrichment of proliferation-associated pathways and leukemic stem cell (LSC) transcriptional programs. Immunogenomic deconvolution further demonstrated that Ficoll artificially inflates estimated CD8⁺ T-cell and monocyte abundances while reducing inferred neutrophil frequencies. Mutation calling from RNA-seq data revealed substantial discrepancies between methods, including failure to detect a clinically relevant DNMT3A R882 mutation in a Ficoll-processed sample. These findings identify leukocyte isolation as a critical pre-analytical variable in AML research and support the systematic use of red blood cell lysis to preserve cellular diversity and avoid unpredictable biases introduced by Ficoll-based isolation.

2025-12-16 | GSE313042 | GEO

Molecular basis of 9G4 B cell autoreactivity in human SLE

Project description:9G4+ IgG antibodies expand in SLE in a disease specific fashion and react with different lupus antigens including B cell antigens and apoptotic cells. Their shared use of VH4-34 represents a unique system to understand the molecular basis of lupus autoreactivity. Understanding the participation of apoptotic cells, a rich source of self-antigens including chromatin, in the diversification and selection of autoreactive memory B cells is particularly important in SLE where these cells accumulate in the germinal centers and may activate pathogenic autoreactive B cells. Our findings indicate that the three mabs with strong apoptotic binding recognized chromatin and individual histones as documented by glomerular proteome microarrays. While the actual antigens mediating APCB remain to be formally elucidating, our initial studies indicate that binding to histone/chromatin may mediate such autoreactivity in at least a fraction of these antibodies Single VH4-34 B cells sorted from IgD-CD27+ memory B cells of SLE patient are sorted and single -RT-PCR is performed to generate monoclonal antibody. 3 monoclonals which were strong apoptotic binders tested for protein array against Chromatin, Histone1, Histone 2A, Histone 2B, Histone 3, Histone 4 and total histones

2013-09-05 | E-GEOD-50609 | biostudies-arrayexpress

Early gene expression changes in peripheral blood leukocytes with rush immunotherapy

2011-12-30 | GSE29521 | GEO

Early gene expression changes in peripheral blood leukocytes with rush immunotherapy

Project description:Peripheral blood mononuclear cells (PBMC) were collected from ficoll gradients of whole blood and immediately processed for total RNA and stored at -80oC until use. Blood was from allergic patients at different timepoints pre or post immunotherapy (RIT). Gene expression was compared for the different timepoints. Blood samples were collected from allergic patients before or after rush immunotherapy (RIT), total RNA was prepared and gene expression assessed by Illumina. Samples were collected pre-rush or at 1 week, 7 weeks, 4 months (and for one patient 5 months) after beginning rush immunotherapy. Blood was taken at each timepoint prior to the patient receiving immunotherapy at each timepoint.

2011-12-30 | E-GEOD-29521 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data